Trial Profile
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: a Randomized Comparison of Aripiprazole, Quetiapine and Ziprasidone Over 1 Year
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Quetiapine (Primary) ; Ziprasidone (Primary)
- Indications Psychotic disorders
- Focus Therapeutic Use
- 02 Sep 2015 New trial record